Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RGS11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MROH6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MSTO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC29A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506418 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TNPO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GATSL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SIK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MEGF6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESYT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR424 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C12orf80 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITGA2B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRKG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC91 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF34 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on